When is active surveillance indicated in the treatment of renal cell carcinoma (RCC)?

Updated: Feb 19, 2021
  • Author: Kush Sachdeva, MD; Chief Editor: E Jason Abel, MD  more...
  • Print

According to American Urological Association management guidelines, active surveillance is a reasonable choice for selected patients for management of localized renal masses. For patients with decreased life expectancy or numerous comorbidities that would make them high risk for intervention, active surveillance is recommended as first choice.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!